Absorption testosterone propionate results negligible. After 8 hours after the single application on intact skin (without occlusive dressings) detected in the systemic circulation of about 0.4% of the active substance. Mometasone is extensively metabolized in the liver, kidneys displayed mainly in small quantities in the bile.
Inflammation and itching dermatoses with measurable glucocorticosteroid therapy.
- Hypersensitivity to any component of the formulation or to the SCS.
- Rosacea, perioral dermatitis.
- Bacterial, viral (Herpes simplex, chicken pox, Herpes zoster), or a fungal infection of the skin.
- Tuberculosis, syphilis.
- Post-vaccination reactions.
- Pregnancy (treatment of large areas of skin, long-term treatment).
- Lactation (used in large doses and / or for a long time).
- Application to the skin of the face and intertriginous skin, the use of occlusive dressings, as well as the treatment of large areas of skin and / or long-term treatment (particularly in children).
Use during pregnancy and lactation
The safety of mometasone furoate during pregnancy and lactation has not been studied.
Corticosteroids cross the placental barrier. Avoid long-term treatment and the use of large doses during pregnancy due to the risk of negative impact on fetal development.
Corticosteroids are excreted in breast milk. In the case where the use of corticosteroids expected at high doses and / or for a long time, discontinue breastfeeding.
Dosage and administration:
Cream Momat thin layer is applied to the affected skin once daily.
The duration of treatment is determined by its efficiency, as well as the tolerance of the patient, presence and severity of side effects.
Rarely – skin irritation and dryness, burning sensation, pruritus, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, the accession of secondary infection, signs of skin atrophy, striae, miliaria. Less than 1% of -. The formation of papules, pustules
When applying external shapes SSC for a long time and / or for the treatment of large areas testosterone propionate results of skin, or with occlusive dressings, especially in children and adolescents, the side effects characteristic of corticosteroids may occur systemic effects, including adrenal insufficiency and Cushing’s syndrome.
Overdose Symptoms : inhibition of the function of the hypothalamic-pituitary-adrenal system, including secondary adrenal insufficiency. Treatment : symptomatic, if necessary – correction of electrolyte imbalance, removal of the drug (for long-term treatment – phasing out).
Interaction with other drugs
cream drug interaction studies have not been conducted Momat with other drugs.
When applied to large areas of the skin for a long time, especially in the application of occlusive dressings may develop corticosteroids systemic effects.
In view of this, patients should be observed for signs of suppression of the hypothalamic-pituitary-adrenal system and the development of Cushing’s syndrome.
Avoid getting cream Momat eyes.
Propylene glycol, which is part of the drug may cause irritation at the site of application. In such cases, discontinue use Momat cream and appropriate treatment.
It should be borne in mind that corticosteroids are able to change some of the manifestations of skin diseases that can complicate diagnosis. In addition, the use of corticosteroids may be the cause of the delay wound healing.
In long-term treatment of GCS sudden cessation of therapy can lead to rebound syndrome, which manifests itself in the form of dermatitis with intense redness and burning sensation. Therefore, after the long course of treatment abolition of the drug must be carried out gradually, for example, switching to intermittent treatment regimen before it is completely stopped. Paediatric use in connection with the fact that the children value surface testosterone propionate results area ratio and body mass is greater than in adults children are at greater risk of suppressing the function of the hypothalamic-pituitary-adrenal system and the development of Cushing’s syndrome when applying any topical corticosteroids. Long-term corticosteroids treatment of children can lead to violations of their growth and development. children should receive the minimum dose sufficient to achieve the effect. eminence labs